Segment Reporting - Summary of Financial Information with Respect to Reportable Segments (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Segment revenues:
Total segment revenues	$ 48,663	$ 32,127
Segment gross profit:
Total segment gross profit	27,983	16,164
Unallocated:
Research and development	(27,822)	(21,448)
Sales and marketing	(6,671)	(5,239)
General and administrative	(22,133)	(13,389)
Loss on equity investments		(1,781)
Change in fair value	(6,164)	24,824
Interest income	328	420
Income tax benefit (expense)	28	(74)
Net loss	(34,451)	(523)
Operating Segments | Software Segment
Segment revenues:
Total segment revenues	33,081	26,340
Segment gross profit:
Total segment gross profit	25,570	20,434
Operating Segments | Drug Discovery Segment
Segment revenues:
Total segment revenues	15,582	5,787
Segment gross profit:
Total segment gross profit	$ 2,413	$ (4,270)